Suchergebnisse - "Hussung, Saskia"

PubPharm (36)

1

Ex vivo modeling of acquired drug resistance in BRAF - mutated pancreatic cancer organoids uncovers individual therapeutic vulnerabilities

enthalten in: Cancer letters | 2024

von Steiner, S. | Pliego-Mendieta, A. | Haberecker, M. | +7

2

Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?

enthalten in: Cancers | 2023

von Cefalì, M. | Scala, I. | Pavone, G. | +11

3

ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer

enthalten in: International journal of cancer | 2022

von Akhoundova, D. | Hussung, S. | Sivakumar, S. | +11

4

Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following curative resection of pancreatic cancer 

enthalten in: ResearchSquare.com | 2022

von Hussung, S. | Akhoundova, D. | Hipp, J. | +9

5

Longitudinal Analysis of Cell-free Mutated KRAS and CA 19-9 Predicts Survival Following Curative Resection of Pancreatic Cancer

enthalten in: ResearchSquare.com | 2022

von Hussung, S. | Akhoundova, D. | Hipp, J. | +9

6

Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following curative resection of pancreatic cancer

enthalten in: ResearchSquare.com | 2022

von Hussung, S. | Akhoundova, D. | Hipp, J. | +9

7

Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following curative resection of pancreatic cancer

enthalten in: ResearchSquare.com | 2022

von Hussung, S. | Akhoundova, D. | Hipp, J. | +9

8

Zirkulierende Tumor-DNA (ctDNA) als molekularer Verlaufsparameter und prognostischer Biomarker bei Pankreaskarzinomen

Erschienen: Dissertation, Albert-Ludwigs-Universität Freiburg im Breisgau, 2022

von Hussung, S.

9

ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer

enthalten in: International Journal of Cancer | 2022

von Akhoundova, D. | Hussung, S. | Sivakumar, S. | +11

10

Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer

enthalten in: JCO precision oncology | 2021

von Akhoundova, D. | Pietge, H. | Hussung, S. | +6